Higher TyG Index Linked to Increased H. pylori Infection Risk and Mortality: Study

Written By :  Medha Baranwal
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2024-08-29 04:00 GMT   |   Update On 2024-08-29 04:58 GMT
Advertisement

China: A higher triglyceride-glucose (TyG) index was significantly linked to an elevated risk of Helicobacter pylori (H. pylori) infection and all-cause mortality among those with the infection, compared to those without, a recent study has revealed.

"Each increase in the TyG index was associated with a greater risk of H. pylori infection, with an odds ratio of 1.189," the researchers reported in Diabetology & Metabolic Syndrome.

Advertisement

The TyG index is a measure derived from triglyceride and glucose levels that is increasingly recognized for its potential role in assessing metabolic health and predicting cardiovascular risk. However, research into the potential link between the TyG index and mortality, particularly among individuals with H. pylori infection, has been limited. To fill this knowledge gap, Lili Huo, Capital Medical University, Beijing, People’s Republic of China, and colleagues seek to examine the relationship between the TyG index and H. pylori infection and determine whether H. pylori infection mediates the association between TyG index levels and all-cause mortality.

For this purpose, the researchers used data from the National Health and Nutrition Examination Survey (NHANES) 1999–2018, involving a final sample of 2,187 participants. They employed univariable and multivariable-adjusted logistic regression analyses to explore the relationship between H. pylori infection and relevant covariates.

To evaluate the association between the TyG index and all-cause mortality among individuals with or without H. pylori infection, they implemented Cox regression analysis and restricted cubic spline analysis.

The following were the key findings of the study:

  • There was a significant positive correlation between the TyG index and an elevated risk of H. pylori infection [OR 1.157]. This correlation persisted even after adjusting for confounding factors [OR 1.189].
  • In patients with positive H. pylori infection, a noteworthy nonlinear correlation between the TyG index and all-cause mortality was identified.
  • With an increase in the TyG index, all-cause mortality exhibited a corresponding rise, particularly following adjustment for all potential confounding factors.
  • In patients with negative H. pylori infection, there was no significant association between the TyG index and all-cause mortality after adjusting for potential confounding factors.

The findings showed that a higher TyG index was associated with an increased risk of H. pylori infection. Participants in the higher quantile of the TyG index had a greater risk of all-cause mortality than those in the same quantile who were H. pylori-positive, as opposed to H. pylori-negative participants.

"The study's observational design limits causality inference, necessitating confirmation through larger prospective studies. Additionally, NHANES participants may not represent the global population, raising questions about the applicability of our findings to diverse ethnic groups," the researchers concluded.

Reference:

Zhu, XY., Xiong, YJ., Meng, XD. et al. Association of triglyceride-glucose index with helicobacter pylori infection and mortality among the US population. Diabetol Metab Syndr 16, 187 (2024). https://doi.org/10.1186/s13098-024-01422-9


Tags:    
Article Source : Diabetology & Metabolic Syndrome

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News